InnovAge Holding Corp. (NASDAQ:INNV) Stock Rockets 30% But Many Are Still Ignoring The Company
InnovAge Holding Corp. (NASDAQ:INNV) shares have had a really impressive month, gaining 30% after a shaky period beforehand. Unfortunately, the gains of the last month did little to right the losse
InnovAge to Launch Up to $5M Buyback Program >INNV
InnovAge to Launch Up to $5M Buyback Program >INNV
Express News | InnovAge Holding Corp. Announces $5.0 Million Share Repurchase Program
InnovAge PACE Recertified as a Great Place to Work
DENVER, June 03, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program
InnovAge Celebrates Grand Opening of Orlando's First PACE Center in Partnership With Orlando Health
ORLANDO, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the
Press Release: InnovAge Welcomes John Koehn as Senior Vice President of External Affairs
InnovAge Welcomes John Koehn as Senior Vice President of External Affairs DENVER, May 20, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (Nasdaq: INNV), an industry leader in providing
Earnings Call Summary | InnovAge Holding(INNV.US) Q3 2024 Earnings Conference
The following is a summary of the InnovAge Holding Corp. (INNV) Q3 2024 Earnings Call Transcript:Financial Performance:InnovAge reported Q3 revenue of $193.1 million, a growth of 2.2% over the last qu
InnovAge Holding Corp. (NASDAQ:INNV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Investors in InnovAge Holding Corp. (NASDAQ:INNV) had a good week, as its shares rose 4.4% to close at US$4.26 following the release of its quarterly results. Revenue of US$193m came in 2.5% ahe
InnovAge Holding Corp (INNV) (Q3 2024) Earnings Call Transcript Highlights: Navigating ...
InnovAge Holding Corp (INNV) Fiscal Q3 Earnings: Navigating Challenges With Improved ...
InnovAge Holding | 10-Q: Quarterly report
Earnings Flash (INNV) INNOVAGE Reports Q3 Revenue $193.1M, Vs. Street Est of $188.3M
04:42 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (INNV) INNOVAGE Reports Q3 Revenue $193.1M, vs. Street Est of $188.3M
InnovAge Holding Q3 2024 GAAP EPS $(0.04), Inline, Sales $193.073M Beat $188.246M Estimate
InnovAge Holding (NASDAQ:INNV) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same per
GUIDANCE: (INNV) INNOVAGE Forecasts Fiscal Year 2024 Revenue Range $725M - $775M
04:41 PM EDT, 05/07/2024 (MT Newswires) -- GUIDANCE: (INNV) INNOVAGE Forecasts Fiscal Year 2024 Revenue Range $725M - $775M
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently With High-Quality Care
LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), the healthcare industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the
InnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024
DENVER, April 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
InnovAge Is Maintained at Neutral by JP Morgan
InnovAge Is Maintained at Neutral by JP Morgan
JP Morgan Maintains Neutral on InnovAge Holding, Lowers Price Target to $6
JP Morgan analyst Lisa Gill maintains InnovAge Holding with a Neutral and lowers the price target from $7 to $6.
No Data